Suppression of serum-induced c-jun expression by activated Ki-ras in human colon cancer cells

M Furuse1, S Shirasawa, K Okumura

  • 1Department of Genetics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-82, Japan.

The Japanese Journal of Human Genetics
|December 31, 2002
PubMed

Insights

Activated Ki-ras signaling in colon cancer cells suppresses c-jun gene induction via protein kinase C (PKC), not the c-Raf pathway. This finding clarifies how Ki-ras impacts immediate early gene expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Activated Kirsten rat sarcoma viral oncogene homolog (Ki-ras) is implicated in colon cancer development and gene expression deregulation.
  • Previous studies linked activated Ki-ras to altered c-myc expression in human colon cancer cell lines.

Purpose of the Study:

  • To investigate the relationship between Ki-ras-mediated signaling and the expression of immediate early genes, specifically c-jun.
  • To elucidate the regulatory mechanisms by which Ki-ras influences c-jun expression in colon cancer cells.

Main Methods:

  • Gene-targeting was used to create human colon cancer cell lines (HK2-6, HKe-3) with and without activated Ki-ras, derived from HCT116.
  • Analysis of c-jun expression upon serum stimulation.
  • Examination of protein kinase C (PKC) and c-Raf activity under serum-starved and stimulated conditions.

Main Results:

  • Serum-induced c-jun expression was rapid and strong in HKe-3 cells (with activated Ki-ras) but not in HCT116 or HK2-6 cells.
  • Phosphorylation of c-Raf was consistent across all cell lines.
  • Cytosolic PKC activity was approximately twofold higher in HKe-3 cells compared to HCT116 cells under both conditions.

Conclusions:

  • Activated Ki-ras appears to suppress the serum responsiveness of c-jun expression in colon cancer cells.
  • The suppression mechanism involves the protein kinase C (PKC) pathway, rather than the c-Raf pathway.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...